Hospital Italiano de Buenos Aires — Buenos Aires

Public research footprint of Hospital Italiano de Buenos Aires, compiled from the ClinicalTrials.gov public registry.

306

Registered studies

128

Active

Recruiting now

118

Completed

Stopped or withdrawn

Most-studied conditions

HR Low-Positive/HER2-Negative Breast Neoplasms · COVID-19 SARS-CoV-2 Infection · Carcinoma, Non-Small-Cell Lung · Non-small Cell Lung Cancer

Recently updated registry entries

NCT05171647 — A Study Evaluating Efficacy and Safety of Mosunetuzumab in Combination With Polatuzumab… (Active Not Recruiting)
NCT06935357 — A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin… (Recruiting)
NCT06081894 — A Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Hospital Italiano de Buenos Aires?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.